Pathstone Holdings
RARE icon

Pathstone Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Pathstone Holdings’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$776K Buy
37,020
+2,681
+8% +$60.4K ﹤0.01% 1539
2025
Q4 		$790K Buy
34,339
+413
+1% +$13.6K ﹤0.01% 1540
2025
Q3 		$1.02M Buy
+33,926
New +$1.02M ﹤0.01% 1416
2025
Q1 		– Sell
-10,363
Closed -$436K – 2360
2024
Q4 		$436K Sell
10,363
-552
-5% -$27.4K ﹤0.01% 1786
2024
Q3 		$606K Buy
10,915
+1,749
+19% +$89.1K ﹤0.01% 1635
2024
Q2 		$377K Buy
9,166
+3,998
+77% +$171K ﹤0.01% 1838
2024
Q1 		$241K Buy
+5,168
New +$244K ﹤0.01% 2047

Other funds holding RARE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return